Stay updated on Daratumumab Combo in Severe Renal Impairment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Severe Renal Impairment Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the page and removed the HHS Vulnerability Disclosure link. The previous Revision: v3.3.2 was deleted.
    Difference
    0.1%
    Check dated 2025-12-22T01:52:05.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added topic 'Multiple myeloma' and related topics including MedlinePlus Genetics, and updated the site revision from v3.3.1 to v3.3.2. These are minor metadata/navigation updates and do not affect the study content, eligibility, or results.
    Difference
    0.2%
    Check dated 2025-11-30T10:20:52.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.3.1' was added, and the terms 'Multiple myeloma', 'MedlinePlus Genetics', and the older revision 'Revision: v3.2.0' were removed, representing maintenance updates rather than alterations to trial information.
    Difference
    0.2%
    Check dated 2025-11-23T07:58:23.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page-level notice about government funding and operating status was removed. No core trial content or eligibility information appears altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T05:52:12.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Minor layout and formatting updates to the Study Details page; core content such as eligibility criteria, outcomes, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-01T23:56:25.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics topic: Multiple myeloma. - Overall, minimal impact on core content beyond the removal of that topic; no additions or other changes.
    Difference
    0.2%
    Check dated 2025-10-18T16:06:05.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Severe Renal Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.